Vaccines (Development)

Licensure Sought for Combination DTAP-Hib Vaccine Use in Children

Published in Vaccine Weekly, April 14th, 1997

Wyeth-Lederle Vaccines and Pediatrics, St. Davids, Pennsylvania, announced that the U.S. Food and Drug Administration (FDA) has accepted for review the Product License Application for a combination vaccine with the requested name of Tetracel.

Licensure of Tetracel has been sought for use in toddlers at 12 to 18 months of age for immunization against four serious childhood illnesses - diphtheria, tetanus, pertussis, and Haemophilus influenzae type b or Hib disease.

Tetracel is a combination vaccine comprised of four components contained in Wyeth-Lederle's two currently marketed vaccines - Acel-Imune Diphtheria and Tetanus Toxoids and Acellular...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Source: Vaccine Weekly (1997-04-14)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry